18-3168921-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000356443.9(MYOM1):āc.1235A>Gā(p.Asp412Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,613,614 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D412V) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000356443.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYOM1 | NM_003803.4 | c.1235A>G | p.Asp412Gly | missense_variant | 9/38 | ENST00000356443.9 | NP_003794.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYOM1 | ENST00000356443.9 | c.1235A>G | p.Asp412Gly | missense_variant | 9/38 | 1 | NM_003803.4 | ENSP00000348821 | P2 | |
MYOM1 | ENST00000261606.11 | c.1235A>G | p.Asp412Gly | missense_variant | 9/37 | 1 | ENSP00000261606 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152088Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000805 AC: 2AN: 248318Hom.: 0 AF XY: 0.00000742 AC XY: 1AN XY: 134712
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1461526Hom.: 0 Cov.: 33 AF XY: 0.00000825 AC XY: 6AN XY: 727026
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152088Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74284
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 07, 2015 | The p.Asp412Gly variant in MYOM1 has not been previously reported in individuals with cardiomyopathy, but has been identified in 1/64312 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP r s767444514). Aspartic acid (Asp) at position 412 is not highly conserved in mamm als or evolutionarily distant species and 15 reptile and fish species carry a gl ycine (Gly) at this position, raising the possibility that this change may be to lerated. However, in silico models suggest this variant may impact splicing, but this information is not predictive enough to determine pathogenicity. In summar y, the clinical significance of the p.Asp412Gly variant is uncertain. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at